Apolipoprotein C‐III as a Potential Modulator of the Association Between HDL‐Cholesterol and Incident Coronary Heart Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Apolipoprotein C‐III as a Potential Modulator of the Association Between HDL‐Cholesterol and Incident Coronary Heart Disease

Published:2012-04-12 Issue:2 Volume:1 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Jensen Majken K.¹,Rimm Eric B.¹²³,Furtado Jeremy D.¹,Sacks Frank M.¹³

Affiliation:

1. From the Department of Nutrition, Harvard School of Public Health, and the Channing Laboratory

2. Department of Epidemiology, Harvard School of Public Health, and the Channing Laboratory

3. Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference44 articles.

1. High density lipoprotein as a protective factor against coronary heart disease

2. Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions

3. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

4. Major Lipids, Apolipoproteins, and Risk of Vascular Disease

5. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipidomic analyses reveal potential biomarkers for predicting death and heart failure after acute myocardial infarction;Clinica Chimica Acta;2024-08

2. Associations of an HDL apolipoproteomic index with cardiometabolic risk factors before and after exercise training in the HERITAGE Family Study;Atherosclerosis;2024-08

3. Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes;European Journal of Clinical Investigation;2024-04-13

4. Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance;Cardiovascular Research;2023-12-01

5. A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease;Pharmaceutics;2023-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3